Teachers Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$2.54M Buy
144,340
+4,946
+4% +$78.1K ﹤0.01% 1840
2018
Q4
$1.79M Buy
139,394
+47,033
+51% +$656K ﹤0.01% 1909
2018
Q3
$1.5M Buy
92,361
+1,283
+1% +$15.2K ﹤0.01% 2123
2018
Q2
$1.03M Buy
91,078
+5,846
+7% +$64.4K ﹤0.01% 2315
2018
Q1
$832K Buy
85,232
+14,240
+20% +$136K ﹤0.01% 2301
2017
Q4
$434K Hold
70,992
﹤0.01% 2628
2017
Q3
$281K Sell
70,992
-998
-1% -$3.39K ﹤0.01% 2861
2017
Q2
$233K Buy
+71,990
New +$276K ﹤0.01% 2971

Other funds holding FATE

Teachers Advisors's FATE Position: Q1 2019 in Review

Teachers Advisors increased its Fate Therapeutics (FATE) stake by 3.5% in Q1 2019, buying an estimated $78.1K and bringing the position to 144,340 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Teachers Advisors first reported a position in FATE in Q2 2017 and has held it in 8 quarters since. 123 funds tracked by Wall St. Rank hold FATE as of Q1 2019.

  • Teachers Advisors held 144,340 shares of Fate Therapeutics worth $2.54M as of Q1 2019.
  • Teachers Advisors bought 4,946 Fate Therapeutics shares in Q1 2019, an estimated $78.1K.
  • Fate Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1840 holding.
  • Teachers Advisors first reported a position in Fate Therapeutics in Q2 2017 and has held it in 8 quarters since.
  • 123 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.